Showing results (71-80 of 396) with videos related to

Sort By:
Pageof 40
Diabetes|June 27, 2023
β-Cell Glucose Sensitivity to Assess Changes in β-Cell Function in Recent-Onset Stage 3 Type 1 DiabetesStephen E Gitelman, Carmella Evans-Molina, Annamaria Guolo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 29, 2024
HPLC-MS/MS method for simultaneous analysis of plasma 2-hydroxybutyrate and 2-hydroxyisobutyrate: Development and clinical significanceBeatrice Campi, Valentina Vitelli, Federica Saponaro, et al.
Diabetes Care|April 28, 2005
Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinideAndrea Mari, Amalia Gastaldelli, James E Foley, et al.
Diabetes|December 24, 2009
Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onsetEle Ferrannini, Andrea Mari, Valentina Nofrate, et al.
Diabetes Care|June 23, 2010
Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trialEle Ferrannini, Silvia Jimenez Ramos, Afshin Salsali, et al.
Diabetes|May 23, 2014
GLP-1 and glucose tolerance after sleeve gastrectomy in morbidly obese subjects with type 2 diabetesAmanda Jiménez, Andrea Mari, Roser Casamitjana, et al.
Endocrinology and Metabolism (Seoul, Korea)|July 4, 2020
Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and SulfonylureaYujin Shin, Ji Hye Moon, Ho Jun Chin, et al.
Diabetes, Obesity & Metabolism|July 14, 2018
Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescentsDomenico Tricò, Andrea Natali, Andrea Mari, et al.
Journal of Clinical Medicine|August 26, 2018
Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 DiabetesMarta Seghieri, Eleni Rebelos, Andrea Mari, et al.
JCI Insight|December 20, 2024
Fasting substrates predict chronic kidney disease progression in CREDENCE trial patients with type 2 diabetesEle Ferrannini, Simona Baldi, Maria Tiziana Scozzaro, et al.
Pageof 40